Table 1. Survival rates of patients after cryosurgery of hepatic tumors.
| Tumor type | Therapy type | Patients | 1 year survival rate (%) | 2 year survival rate (%) | 3 year survival rate (%) | 4 year survival rate (%) | 5 year survival rate (%) | |
|---|---|---|---|---|---|---|---|---|
| Zhou et al. 32–33 | HCC | CRY | 48 | 81.3 | 62.1 | 47.6 | 44.4 | - |
| Chen et al. 20 | HCC | CRY | - | 81.4 | - | 60.3 | - | - |
| Li et al. 36 | SHCC | CRY | - | 100.0 | - | 77.6 | 70.7 | - |
| Xu et al. 37 | Colorectal liver metastases | CRY | 326 | 78.0 | 62.0 | 41.0 | 34.0 | 23.0 |
| Qian et al. 38 | Metastatic liver malignancy | CRY | 22 | 81.8 | 22.7 | - | - | - |
| Chen et al. 39 | Secondary Liver cancer | CRY | - | 80.2 | - | - | - | - |
| Recurrent liver cancer | CRY | - | 46.2 | - | - | - | - | |
| Han et al. 40 | HCC | CRY | 116 | 85.7 | 64.3 | 32.1 | - | - |
| Xu et al. 42 | HCC | CRY | 420 | 73.0 | 54.0 | - | 49.0 | 39.0 |
| HCC | TACE+CRY | - | 71.0 | 61.0 | - | 29.0 | 23.0 |
Note: SHCC, small HCC; CRY, cryotherapy